Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on February 2, 2015. The filing reports a corporate governance event: the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and compensatory arrangements.
Material Changes
- Board Appointment: Jeffrey O'Donnell was appointed to the Board of Directors, effective February 2, 2015. He previously served as a director from October 2011 to February 2014.
- Compensatory Arrangement: In connection with his appointment, Mr. O'Donnell was granted a stock option to purchase 200,000 shares of common stock.
- Option Terms: The exercise price is $2.50 per share (fair market value on the grant date). The options vest 50% on the first and second annual anniversaries of the grant date and expire seven years after the grant date.
Outlook, Risks, and Management Commentary
Management commentary highlights that Mr. O'Donnell's return brings extensive experience in the healthcare industry, including a traditional corporate background and emerging growth experience. He has served as an executive officer and director for several large healthcare and medical device companies, including PhotoMedex, Inc., Embrella Cardiovascular, Inc., and currently holds board positions at AltheRx Pharmaceuticals, CD Diagnostics, Inc., Vertical Capital, Trice Orthopedics, Inc., and MELA Sciences, Inc.
The filing does not disclose specific risks, contingencies, or unusual items beyond the standard terms of the equity grant.
Investor Verification Checklist
- Verify the total number of outstanding shares and the potential dilution impact of the 200,000 new options granted.
- Confirm the current fair market value of the stock relative to the $2.50 exercise price.
- Review the BioSig Technologies, Inc. 2012 Equity Incentive Plan for any caps or restrictions that may affect this grant.
- Check for any subsequent filings regarding Mr. O'Donnell's tenure or additional compensation.